Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamic Study of ASP1585 - Verification of Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

NCT02531204 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02531204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02531204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamic Study of ASP1585 - Verification of Bioequivalence Between ASP1585 Granules and ASP1585 Capsules
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
February 28, 2015
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, urine phosphorus excretion